Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for LifeMD Inc. (LFMD:NASDAQ), powered by AI.
LifeMD Inc. is currently trading at $4.82. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for LifeMD Inc. on Alpha Lenz.
View LifeMD Inc.'s valuation metrics on Alpha Lenz.
“LifeMD Inc.'s ROE is 162.5%. Explore profitability and growth together.”
Ask for details →LifeMD Inc. is a provider of direct-to-patient healthcare services and pharmaceuticals, capitalizing on the increasing trend of telemedicine and online healthcare solutions. The primary function of LifeMD is to deliver accessible healthcare and medical services across the United States, utilizing a combination of telehealth technology and proprietary online platforms. This approach enables LifeMD to offer a range of services such as medical consultations, prescription medications, and wellness products, making healthcare more convenient and affordable for a broader audience. Notably impacting the healthcare and pharmaceutical sectors, LifeMD stands out by addressing the challenges faced by traditional healthcare systems, such as accessibility and cost, through its innovative digital solutions. The company's direct-to-consumer model is significant in the growing telehealth market, especially as the demand for virtual health services continues to rise. LifeMD Inc. plays a crucial role in expanding the reach of medical services to underserved populations and in transforming the way healthcare is delivered, fitting into the broader trend of digital transformation across various industries.
“LifeMD Inc.'s ROE is 162.5%. Explore profitability and growth together.”
Ask for details →LifeMD Inc. (ticker: LFMD) is a company listed on NASDAQ in the Healthcare sector (Health Information Services). It has approximately 304 employees.
The current price is $4.82 with a P/E ratio of -x and P/B of -x.
ROE is 162.46% and operating margin is -3.95%. Annual revenue is $194M.